Projects

A novel therapeutic intervention for cystinosis by pharmacologically modulating autophagy- lysosomal pathway to ameliorate disease pathology

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2027

Project Lead

Authors

Dr. Ravi Manjithaya, Dr. Anil Vasudevan, Dr. Rakesh Mishra, Dr. Vasanth Thamodaran,

Project Status

ongoing